The stock looks like a great pick to help turn investors into multimillionaires, given enough time. Everyone should save ...

The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

This run could be short-lived.

Eli Casdin, Casdin Capital CEO, joins 'Closing Bell' to discuss the biotech sector, the stocks Casdin favors and much more.

Today, you can pick up a share of Iovance for less than $3, making it accessible to many investors. The key is to hold onto ...

Matthew Kapusta, CEO of uniQure N.V., sold 14,581 shares at $9.06 on March 4 for about $132,103, reducing his stake by 2.16%, ...

Small and mid-cap biotech stocks entered 2025 like a compressed spring, and it finally snapped higher. “Biotech was a coiled spring following several quarters of underperformance,” Dr. Terry Smith, ...

In this article, we will be taking a look at the 20 Best Biotech Stocks Under $20 to Buy Now. The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of ...

Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has three promising candidates in early development as well as its only ...

Grail (GRAL) stock is plummeting after the company's three-year cancer screening trial failed to meet its main goal ...